Those using wild abalone oil kept saying the same things...
Long before we ran our community study, customers were telling us what wild abalone oil did for them. Four things came up again and again: energy, skin, sleep, and joints. When we followed 42 people through their first month, those four were exactly what they reported. What follows is an honest account of how well the science does, and doesn't, back each one up.
Energy
Energy was the single most-reported benefit in our month-one community study, 15 of 42 named it, with men reporting it at nearly double the rate of women, and most describing it as something they noticed at the end of the day rather than as a morning jolt.
Here's the part we won't dress up: nobody has run a proper trial testing whether marine omega-3s make healthy people feel more energetic. It hasn't been done. What has been shown is upstream of that. In a four-month controlled trial in healthy middle-aged adults, omega-3 supplementation held inflammatory markers steady while the placebo group's rose by over a third, and in a separate study using actual muscle biopsies, EPA was found to embed itself in the mitochondrial membranes of human skeletal muscle and improve how efficiently those cells handle energy. Wild abalone also carries an unusual amount of palmitoleic acid, a fatty acid distinctive enough that researchers call it a lipokine, a fat that behaves like a hormone, carrying metabolic signals between tissues. That's suggestive biology, and it's honestly why we're interested. But suggestive biology isn't a promise, and if you're expecting the feeling of a coffee, this isn't that. Our customers report a slow shift in baseline over weeks. We're reporting what they told us, not what a trial proved.
Skin
Skin was the second most-cited benefit in community study feedback (14 of 42), skewing strongly female and strongest in the 30–50 age range, with reports ranging from reduced eczema and psoriasis severity to stronger nails and less "dullness" after poor sleep.
Palmitoleic acid, the same omega-7 that the skin's own sebaceous glands produce and found here as one of the highest natural concentrations of it in any marine source, has been shown in a 12-week randomised, placebo-controlled trial to significantly improve skin hydration and reduce transepidermal water loss. ETA adds a second, distinct mechanism: with a large population study finding dietary ETA intake associated with meaningfully lower psoriasis risk, an association EPA and DHA didn't show on their own, suggesting this is a fatty acid doing something the more commonly marketed omega-3s don't.
Sleep
Sleep was the third-most reported benefit (13 of 42), and it showed the sharpest pattern in our data: 60% of women aged 30 to 50 named it, more than any other group in the study. What they described wasn't falling asleep faster, it was sleeping deeper, and waking up feeling like the night had actually counted. That distinction turns out to matter.
A 2024 pooled analysis of eight controlled trials found marine omega-3s significantly improved sleep efficiency, the share of time in bed actually spent asleep and improved how people rated their own sleep. What it did not find was any change in how long people took to fall asleep or how many hours they slept. Quality, not quantity. It's a close enough match to what our customers reported that we'd have been suspicious if we'd invented it. Two honest caveats: the trials varied a lot in dose and design, and one review looking specifically at postmenopausal women found the evidence too thin to call. This isn't a sleeping pill and it doesn't behave like one.
Joints
A quarter of our community study group, 10 of 42, noticed something in their joints, and it's the one benefit that gets stronger with age rather than fading: by 50+, it overtakes skin and energy as the top thing women mention.
The broader evidence backs that up, modestly. A 2023 pooled analysis of nine randomised controlled trials, just over 2,000 people with osteoarthritis, found marine omega-3s produced a small but statistically real reduction in joint pain and improvement in function, with no meaningful side effects. Small is the operative word. Nobody should expect this to work like an anti-inflammatory drug, and the trials disagree with each other enough that we'd rather undersell it than promise a result you don't get. Where wild abalone gets more interesting is DPA. DPA isn't just another anti-inflammatory; it's the raw material for the molecules that tell the body to stop inflaming and start repairing. In a human crossover trial, DPA raised those molecules more than twenty-fold. EPA didn't move them at all. There's also ETA, the fatty acid shared with New Zealand green-lipped mussel, which showed real promise in arthritic dogs, though the human research on it is thin enough that we'd call it a lead worth following rather than a proven benefit. That's the honest shape of it: a modest effect the wider science supports, and two fatty acids the joint supplement aisle hasn't caught up with yet.
Energy
Kiecolt-Glaser, J. K., Belury, M. A., Andridge, R., Malarkey, W. B., Hwang, B. S., & Glaser, R. (2012). Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: A randomized controlled trial. Brain, Behavior, and Immunity, 26(6), 988–995. https://doi.org/10.1016/j.bbi.2012.05.01
Yang, Z.-H., Miyahara, H., & Hatanaka, A. (2011). Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay mice with genetic type 2 diabetes. Lipids in Health and Disease, 10, Article 120.
Herbst, E. A., et al. (2014). Omega-3 supplementation alters mitochondrial membrane composition and respiration kinetics in human skeletal muscle. The Journal of Physiology, 592(6), 1341–1352.
Cao, H., et al. (2008). Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell, 134(6), 933–944.
Souza, C. O., et al. (2018). Is palmitoleic acid a plausible non-pharmacological strategy to prevent or control chronic metabolic and inflammatory disorders? Molecular Nutrition & Food Research, 62(1), Article 1700504.
Skin
Clark, C. C. T., Taghizadeh, M., Nahavandi, M., & Jafarnejad, S. (2019). Efficacy of ω-3 supplementation in patients with psoriasis: A meta-analysis of randomized controlled trials. Clinical Rheumatology, 38(4), 977–988. https://doi.org/10.1007/s10067-019-04456-x
Chen, X., Hong, S., Sun, X., Xu, W., Li, H., Ma, T., Zheng, Q., Zhao, H., Zhou, Y., Qiang, Y., Li, B., & Li, X. (2020). Efficacy of fish oil and its components in the management of psoriasis: A systematic review of 18 randomized controlled trials. Nutrition Reviews, 78(10), 827–840. https://doi.org/10.1093/nutrit/nuz098
Koh, Y. G., Seok, J., et al. (2023). Efficacy and safety of oral palmitoleic acid supplementation for skin barrier improvement: A 12-week, randomized, double-blinded, placebo-controlled study. Heliyon, 9(6), Article e16711.
Wille, J. J., & Kydonieus, A. (2003). Palmitoleic acid isomer (C16:1Δ6) in human skin sebum is effective against gram-positive bacteria. Skin Pharmacology and Applied Skin Physiology, 16(3), 176–187.
Sleep
Shimizu, K., Kuramochi, Y., & Hayamizu, K. (2024). Effect of omega-3 fatty acids on sleep: A systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Biochemistry and Nutrition, 75(3), 204–212. https://doi.org/10.3164/jcbn.24-36
Dai, Y., & Liu, J. (2021). Omega-3 long-chain polyunsaturated fatty acid and sleep: A systematic review and meta-analysis of randomized controlled trials and longitudinal studies. Nutrition Reviews, 79(8), 847–868.
Suneson, K., et al. (2024). Omega-3 fatty acids for inflamed depression — A match/mismatch study. Brain, Behavior, and Immunity, 118, 192–201.
Joints
Deng, W., Yi, Z., Yin, E., Lu, R., You, H., & Yuan, X. (2023). Effect of omega-3 polyunsaturated fatty acids supplementation for patients with osteoarthritis: A meta-analysis. Journal of Orthopaedic Surgery and Research, 18, Article 381. https://doi.org/10.1186/s13018-023-03855-w
Markworth, J. F., Kaur, G., Miller, E. G., Larsen, A. E., Sinclair, A. J., Maddipati, K. R., & Cameron-Smith, D. (2016). Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid. The FASEB Journal, 30(11), 3714–3725.
Bierer, T. L., & Bui, L. M. (2002). Improvement of arthritic signs in dogs fed green-lipped mussel (Perna canaliculus). The Journal of Nutrition, 132(6), 1634S–1636S.
Pearson, W., Orth, M. W., Karrow, N. A., MacLusky, N. J., & Lindinger, M. I. (2007). Anti-inflammatory and chondroprotective effects of nutraceuticals from Sasha's Blend in a cartilage explant model of inflammation. Molecular Nutrition & Food Research, 51(8), 1020–1030. https://doi.org/10.1002/mnfr.200700026
Tian, Y., et al. (2017). Anti-inflammatory effect of n-3 docosapentaenoic acid on RAW264.7 cells. Journal of Oleo Science, 66(10), 1149–1156.
Stebbings, S., Gray, A., Schneiders, A. G., & Sansom, A. (2017). A randomized double-blind placebo-controlled trial to investigate the effectiveness and safety of a novel green-lipped mussel extract—BioLex®—for managing pain in moderate to severe osteoarthritis of the hip and knee. BMC Complementary and Alternative Medicine, 17, Article 416. https://doi.org/10.1186/s12906-017-1907-9